Skip to main content
Clinical Trials/NCT06054620
NCT06054620RecruitingNot Applicable

The Effect of Exercise and Presleep Nutrition on Muscle Connective Tissue Remodelling

University of Toronto1 site in 1 country12 target enrollmentStarted: September 15, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
12
Locations
1
Primary Endpoint
Enrichment of Muscle Collagen

Study Overview

Brief Summary

The primary objective of this study will be to determine the influence of a presleep vitamin C-enriched, collagen-modelled supplement (CVC) on the metabolic fate of dietary glycine using a [2H5]glycine tracer within the intramuscular connective tissue at rest and after a bout of resistance exercise. Other outcomes will be related to regulation collagen remodelling in skeletal muscle.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
None

Masking Description

Double blinded (investigators and participants). A lab member external to the investigation will code items for the intervention.

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy, recreationally active, male and female participants.
  • •Healthy will be defined as someone who does not have a health condition that would compromise their ability to safely participate in the strenuous physical activity involved in our study as screened for by the Get Active Questionnaire.
  • •Willing to abstain from resistance exercise for 2 weeks prior to the first metabolic trial and for the duration of the study.
  • •Participants must be able to abstain from lower-body resistance and/or plyometric exercise for at least 2 weeks prior to the first metabolic trial.
  • •Participants will be aged 18-35 years old.
  • •Participants must be normal to overweight (e.g., BMI 18.5-30).
  • •Participants are willing to abide by the compliance rules of this study (e.g., abstain from physical activity and alcohol 48h prior to each trial).
  • •Self-reported regular menstrual cycle (25-35d) within the last 3 months (female participants).

Exclusion Criteria

  • •Inability to adhere to any of the compliance rules judged by principal investigator or medical doctor.
  • •Self-reported regular tobacco use.
  • •Self-reported illicit drug use (e.g. growth hormone, testosterone, etc.).
  • •Regular use of anti-inflammatory drugs (e.g., ibuprofen).
  • •Self-reported regularly sleeping less than an average of 7 hours over 3 days (minimum recommended daily amount).
  • •Individuals who have participated in studies within the past year involving any of the stable isotopes in the study.
  • •Use of birth control and discontinued use in the last 3-months (female only).

Arms & Interventions

Collagen and Vitamin C

Active Comparator

Intervention: Collagen and Vitamin C (Dietary Supplement)

Carbohydrate Placebo

Placebo Comparator

Intervention: Carbohydrate Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Enrichment of Muscle Collagen

Time Frame: 9 hours

Overnight incorporation of orally ingested amino acid tracer (D5 Gly and D5 Phe) into mature collagen protein isolated from skeletal muscle biopsy samples taken 9 hours after consumption of the tracer-containing supplement (CVC or PLA) and rest or resistance exercise. Enrichment will be quantified via tandem LC-MS/MS.

Secondary Outcomes

  • Area of muscle with localized collagen remodelling(9 hours)
  • Concentration of Urinary Growth Hormone(8 hours)
  • Enrichment of Myofibrillar Protein(9 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Daniel Moore

Associate Professor

University of Toronto

Study Sites (1)

Loading locations...

Similar Trials